BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9858540)

  • 1. A novel intron element operates posttranscriptionally To regulate human N-myc expression.
    Sivak LE; Pont-Kingdon G; Le K; Mayr G; Tai KF; Stevens BT; Carroll WL
    Mol Cell Biol; 1999 Jan; 19(1):155-63. PubMed ID: 9858540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?
    Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL
    Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression.
    Iyengar RV; Pawlik CA; Krull EJ; Phelps DA; Burger RA; Harris LC; Potter PM; Danks MK
    Cancer Res; 2001 Apr; 61(7):3045-52. PubMed ID: 11306486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antisense promoter of the murine c-myc gene is localized within intron 2.
    Spicer DB; Sonenshein GE
    Mol Cell Biol; 1992 Mar; 12(3):1324-9. PubMed ID: 1545813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct promoters drive transcription of the human D1A dopamine receptor gene.
    Lee SH; Minowa MT; Mouradian MM
    J Biol Chem; 1996 Oct; 271(41):25292-9. PubMed ID: 8810292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
    Bauer SR; Piechaczyk M; Nordan RP; Owens JD; Nepveu A; Marcu KB; Mushinski JF
    Oncogene; 1989 May; 4(5):615-23. PubMed ID: 2657576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of the eosinophil-derived neurotoxin ribonuclease (RNS2) gene requires interaction between the promoter and intron.
    Tiffany HL; Handen JS; Rosenberg HF
    J Biol Chem; 1996 May; 271(21):12387-93. PubMed ID: 8647842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of N-myc gene expression: use of an adenovirus vector to demonstrate posttranscriptional control.
    Babiss LE; Friedman JM
    Mol Cell Biol; 1990 Dec; 10(12):6700-8. PubMed ID: 2147226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of the human N-myc promoter region during development in a transgenic mouse model.
    Tai KF; Rogers SW; Pont-Kingdon G; Carroll WL
    Pediatr Res; 1999 Sep; 46(3):255-62. PubMed ID: 10473038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells.
    Wada RK; Seeger RC; Reynolds CP; Alloggiamento T; Yamashiro JM; Ruland C; Black AC; Rosenblatt JD
    Oncogene; 1992 Apr; 7(4):711-7. PubMed ID: 1565467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coding elements in exons 2 and 3 target c-myc mRNA downregulation during myogenic differentiation.
    Yeilding NM; Lee WM
    Mol Cell Biol; 1997 May; 17(5):2698-707. PubMed ID: 9111340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ornithine decarboxylase gene is a transcriptional target of c-Myc.
    Bello-Fernandez C; Packham G; Cleveland JL
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7804-8. PubMed ID: 8356088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen inducibility of c-Ha-ras transcription in breast cancer cells. Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene.
    Pethe V; Shekhar PV
    J Biol Chem; 1999 Oct; 274(43):30969-78. PubMed ID: 10521493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of c-myc regulation by c-Myb in different cell lineages.
    Cogswell JP; Cogswell PC; Kuehl WM; Cuddihy AM; Bender TM; Engelke U; Marcu KB; Ting JP
    Mol Cell Biol; 1993 May; 13(5):2858-69. PubMed ID: 8474446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1.
    Reisman D; Greenberg M; Rotter V
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5146-50. PubMed ID: 2839831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts.
    Krystal GW; Armstrong BC; Battey JF
    Mol Cell Biol; 1990 Aug; 10(8):4180-91. PubMed ID: 1695323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
    Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL
    Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type-specific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer.
    Woodruff KA; Rosenblatt JD; Moore TB; Medzoyan RH; Pai DS; Noland JL; Yamashiro JM; Wada RK
    Oncogene; 1995 Apr; 10(7):1335-41. PubMed ID: 7731684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the promoter region of the human thrombospondin gene. DNA sequences within the first intron increase transcription.
    Laherty CD; Gierman TM; Dixit VM
    J Biol Chem; 1989 Jul; 264(19):11222-7. PubMed ID: 2544587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo.
    Strobl LJ; Eick D
    EMBO J; 1992 Sep; 11(9):3307-14. PubMed ID: 1505520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.